Nurami Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $6M
Latest Deal Amount
  • Investors
  • 5

Nurami General Information

Description

Developer of biomaterials and nanofiber-based matrix intended to improve patient outcomes in various surgical procedures. The company's matrices combine porous scaffold for tissue regeneration enhancement with a novel temperature-sensitive sealant to prevent the entry of pathogens and CSF leaks, enabling surgeons to seamlessly answer the unmet needs of their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Biotechnology
Primary Office
  • P.O.B 33964
  • Haifa 3303203
  • Israel
+972 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nurami Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 02-Nov-2020 $6M 00.000 Completed Clinical Trials - General
3. Early Stage VC 20-Dec-2016 00000 00.000 00.000 Completed Generating Revenue
2. Grant $882K $800K Completed Startup
1. Seed Round 01-Jan-2014 $800K $800K 00.00 Completed Startup
To view Nurami’s complete valuation and funding history, request access »

Nurami Executive Team (4)

Name Title Board Seat Contact Info
Nora Nseir Co-Founder, Co-Chief Executive Officer and Chief Technology Officer
Hannoch Marksheid Ph.D Co-Chief Executive Officer & Business Development Manager
Nizar Mishael Chief Financial Officer
Amir Bahar Ph.D Co-Founder & Chief Operating Officer
To view Nurami’s complete executive team members history, request access »

Nurami Board Members (2)

Name Representing Role Since
Doron Birger Self Chairman 000 0000
Zohar Gendler Next Generation Technology Board Member 000 0000
To view Nurami’s complete board members history, request access »

Nurami Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nurami Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Almeda Ventures Venture Capital Minority 000 0000 000000 0
GlenRock Israel Venture Capital Minority 000 0000 000000 0
Alfred Mann Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
Israel Innovation Authority Government Minority 000 0000 000000 0
Next Generation Technology Venture Capital Minority 000 0000 000000 0
To view Nurami’s complete investors history, request access »